Platform
Features
Pricing
0 followers
Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.
Industries
Headquarters
Employees
Links
Stephen J. Russell
5 members
4 members
Entrada Therapeutics
1 follower
Scholar Rock
Thermo Fisher Scientific
156 followers
GRAIL
27 followers
Cytokinetics
11 followers
Pendulum
4 followers
Caris Life Sciences
2 followers
BridgeBio
Immunome
Vial
5 followers
Lightspeed Venture Partners
33 followers
Explore companies